Encyclopedia

  • Development and validation of RP-HPLC method for simultaneous estimation of Montelukast Sodium and Fexofenadine hydrochloride in combined dosage form
  • Add time:07/14/2019         Source:sciencedirect.com

    A simple, fast and precise reverse phase high performance liquid chromatographic method has been developed for the simultaneous determination of Montelukast Sodium (MONT) and Fexofenadine hydrochloride (FEXO). The chromatographic separation was achieved on X-bridge C18 column (250 mm × 4.6 mm, 5 μm) as stationary phase with a mobile phase comprising of 50 mM Sodium acetate buffer:acetonitrile:methanol (25:35:40) adjust pH 8.2 with 5% o-phosphoric acid at a flow rate of 1.0 mL/min, column temperature of 40 ± 2 °C and UV detection at 210 nm. The retention time of Montelukast Sodium and Fexofenadine hydrochloride were 3.43 min, and 8.22 min respectively. The linearity were found to be in the range of 12.5–37.5 μg/mL and 150–450 μg/mL for Montelukast Sodium and Fexofenadine hydrochloride with correlation coefficient greater than 0.999. The proposed methods were validated as per ICH guidelines and successfully applied for the determination of investigated drugs in tablets.

    We also recommend Trading Suppliers and Manufacturers of 5-butyl-1-(1-methylethyl)-1,5-dihydro-4H-imidazo[4,5-c]quinolin-4-one hydrochloride (cas 133306-09-9). Pls Click Website Link as below: cas 133306-09-9 suppliers


    Prev:Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists
    Next: ELTA: Enzymatic Labeling of Terminal ADP-Ribose)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View